{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:49:22Z","timestamp":1779929362055,"version":"3.53.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.eprac.2022.01.008","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T02:09:24Z","timestamp":1643076564000},"page":"378-383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prevalence and Clinical Determinants of Obesity in Adults With Type 1 Diabetes Mellitus: A Single-Center Retrospective Observational Study"],"prefix":"10.1016","volume":"28","author":[{"given":"Yumiko","family":"Tsushima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Bena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta R.","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.eprac.2022.01.008_bib1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2337\/dc15-0078","article-title":"Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange Clinic Registry","volume":"38","author":"Miller","year":"2015","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.eprac.2022.01.008_bib2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1464-5491.2010.02956.x","article-title":"Temporal patterns in overweight and obesity in type 1 diabetes","volume":"27","author":"Conway","year":"2010","journal-title":"Diabet Med"},{"issue":"28","key":"10.1016\/j.eprac.2022.01.008_bib3","article-title":"Double-diabetes in a real-world sample of 2711 individuals: associated with insulin treatment or part of the heterogeneity of type 1 diabetes?","volume":"8","author":"Giuffrida","year":"2016","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.eprac.2022.01.008_bib4","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.2147\/DDDT.S79322","article-title":"Insulin administration: present strategies and future directions for a noninvasive (possibly more physiological) delivery","volume":"9","author":"Matteucci","year":"2015","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"10.1016\/j.eprac.2022.01.008_bib5","first-page":"CD005103","article-title":"Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus","author":"Misso","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.eprac.2022.01.008_bib6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.diabres.2012.12.025","article-title":"Cross-sectional and longitudinal relationships of body mass index with glycemic control in children and adolescents with type 1 diabetes mellitus","volume":"100","author":"Nansel","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"issue":"14","key":"10.1016\/j.eprac.2022.01.008_bib7","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0002-9149(99)80683-3","article-title":"Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial","volume":"75","year":"1995","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.eprac.2022.01.008_bib8","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2337\/dc18-1446","article-title":"BMI, mortality, and cardiovascular outcomes in type 1 diabetes: findings against an obesity paradox","volume":"42","author":"Edqvist","year":"2019","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.eprac.2022.01.008_bib9","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.2337\/dc16-2523","article-title":"Impact of excessive weight gain on cardiovascular outcomes in type 1 diabetes: results from the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Study","volume":"40","author":"Purnell","year":"2017","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.eprac.2022.01.008_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/1932296813520205","article-title":"Changes in insulin requirements from the onset of continuous subcutaneous insulin infusion (CSII) until optimization of glycemic control","volume":"8","author":"Chico","year":"2014","journal-title":"J\u00a0Diabetes Sci Technol"},{"issue":"10","key":"10.1016\/j.eprac.2022.01.008_bib11","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.numecd.2019.06.008","article-title":"Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: a 10-year retrospective controlled study","volume":"29","author":"Alderisio","year":"2019","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"12","key":"10.1016\/j.eprac.2022.01.008_bib12","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.2337\/dc15-1730","article-title":"Efficacy and safety of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, as add-on to insulin in patients with type 1 diabetes","volume":"38","author":"Henry","year":"2015","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.eprac.2022.01.008_bib13","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1177\/1060028016651279","article-title":"GLP-1 agonists in type 1 diabetes mellitus","volume":"50","author":"Janzen","year":"2016","journal-title":"Ann Pharmacother"},{"issue":"8","key":"10.1016\/j.eprac.2022.01.008_bib14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S2213-8587(17)30194-8","article-title":"Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial","volume":"5","author":"Petrie","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"10.1016\/j.eprac.2022.01.008_bib15","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2337\/dc14-2806","article-title":"Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, as adjunct therapy to insulin in type 1 diabetes","volume":"38","author":"Sands","year":"2015","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.eprac.2022.01.008_bib16","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/aje\/kwk052","article-title":"Relaxing the rule of ten events per variable in logistic and Cox regression","volume":"165","author":"Vittinghoff","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"10","key":"10.1016\/j.eprac.2022.01.008_bib17","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.2337\/dc06-0042","article-title":"A\u00a0double-blind, placebo-controlled trial assessing pramlintide treatment in the setting of intensive insulin therapy in type 1 diabetes","volume":"29","author":"Edelman","year":"2006","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.eprac.2022.01.008_bib18","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1464-5491.2004.01319.x","article-title":"Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in type 1 diabetes mellitus: a 1-year, randomized controlled trial","volume":"21","author":"Ratner","year":"2004","journal-title":"Diabet Med"},{"issue":"5","key":"10.1016\/j.eprac.2022.01.008_bib19","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00125-009-1636-9","article-title":"The use of metformin in type 1 diabetes: a systematic review of efficacy","volume":"53","author":"Vella","year":"2010","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.eprac.2022.01.008_bib20","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s13300-017-0282-3","article-title":"Effects of insulin plus glucagon-like peptide-1 receptor agonists (GLP-1RAs) in treating type 1 diabetes mellitus: a systematic review and meta-analysis","volume":"8","author":"Wang","year":"2017","journal-title":"Diabetes Ther"},{"issue":"12","key":"10.1016\/j.eprac.2022.01.008_bib21","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S2213-8587(19)30154-8","article-title":"SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: balancing benefits and risks","volume":"7","author":"Taylor","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2022.01.008_bib22","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1210\/jc.2014-3415","article-title":"Pharmacological management of obesity: an Endocrine Society Clinical Practice Guideline","volume":"100","author":"Apovian","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2022.01.008_bib23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/dmrr.2565","article-title":"Prevalence of overweight, obesity and metabolic syndrome components in children, adolescents and young adults with type 1 diabetes mellitus","volume":"31","author":"Pinhas-Hamiel","year":"2015","journal-title":"Diabetes Metab Res Rev"},{"issue":"2","key":"10.1016\/j.eprac.2022.01.008_bib24","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1016\/j.orcp.2013.03.007","article-title":"Obesity is associated with retinopathy and macrovascular disease in type 1 diabetes","volume":"8","author":"Price","year":"2014","journal-title":"Obes Res Clin Pract"},{"issue":"9786","key":"10.1016\/j.eprac.2022.01.008_bib25","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0140-6736(11)60471-6","article-title":"Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study","volume":"378","author":"Lind","year":"2011","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.eprac.2022.01.008_bib26","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2337\/dc15-2732","article-title":"Bariatric surgery in obese patients with type 1 diabetes","volume":"39","author":"Kirwan","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2022.01.008_bib27","doi-asserted-by":"crossref","DOI":"10.1177\/2042018818822207","article-title":"Bariatric surgery in patients with type 1 diabetes: special considerations are warranted","volume":"10","author":"Landau","year":"2019","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.eprac.2022.01.008_bib28","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.2337\/dc20-0388","article-title":"Potential benefits and harms of gastric bypass surgery in obese individuals with type 1 diabetes: a nationwide, matched, observational cohort study","volume":"43","author":"H\u00f6skuldsd\u00f3ttir","year":"2020","journal-title":"Diabetes Care"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22000325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22000325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:12:42Z","timestamp":1761516762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X22000325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1530891X22000325"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2022.01.008","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and Clinical Determinants of Obesity in Adults With Type 1 Diabetes Mellitus: A Single-Center Retrospective Observational Study","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2022.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 AACE. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}